May 4, 2026 Serum Institute of India Entered Licence Agreement with the University of Oxford to Advance the Development of a Next-Generation Multi-Stage Malaria Vaccine Malaria Members' achievements Vaccines & immunization
April 24, 2026 DCVMN Awarded 2026 MahnHoon Award for Advancing Vaccine Equity CEO DCVMN achievements WeConnectToProtect
April 23, 2026 From Lecture Halls to Manufacturing Floors: DCVMN in South Korea DCVMN achievements DCVMN Advocacy Members
April 17, 2026 Another Succesful DCVMN Technology Transfer Training Delivered DCVMN achievements Technology Transfer Workforce Training
April 3, 2026 DCVMN at the World Vaccine Congress 2026: Advancing AI, Sustainability, and Global Vaccine Equity DCVMN Advocacy DCVMN Board Vaccines & immunization
February 23, 2026 DCVMN Launches the 7th Edition of its Technology Transfer Training DCVMN achievements Technology Transfer Workforce Training
February 17, 2026 Regulatory and PV Working Groups Constructing the Road Ahead DCVMN achievements DCVMN Working Groups WeConnectToProtect
December 18, 2025 DCVMN and ICGEB Successfully Conclude the 6th Edition of the Technology Transfer Training Technology Transfer Workforce Training
November 26, 2025 DCVMN at the Pharma Connect Congress 2025 DCVMN Advocacy developingcountries Vaccines & immunization
November 10, 2025 DCVMN and ICGEB Launch the 6th Edition of the Technology Transfer Training Programme DCVMN achievements Technology Transfer Workforce Training
November 1, 2025 Regulatory WG New Publication on Adaptive Clinical Trial Designs for Rapid Vaccine Development DCVMN achievements DCVMN Working Groups Vaccine Development
